INTERNATIONAL PATENT: YUNGJIN PHARM. CO., LTD., 영진약품 주식회사 FILES APPLICATION FOR "NOVEL TABLET HAVING IMPROVED DISSOLUTION RATE COMPRISING NINTEDANIB OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND PREPARATION METHOD THEREFOR"

GENEVA, Dec. 16 -- YUNGJIN PHARM. CO., LTD. (13 Olympic-ro 35da-gilSongpa-guSeoul 05510), 영진약품 주식회사 (서울특별시송파구올림픽로35다길 13) filed a patent application (PCT/KR2024/013188) for "NOVEL TABLET HAVING IMPROVED DISSOLUTION RATE COMPRISING NINTEDANIB OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND PREPARATION METHOD THEREFOR" on Sep 02, 2024. With publication no. WO/2025/254255, the details related to the patent application was published on Dec 11, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellect...